Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Higher-dose weight loss injections now available." A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The Injection and ...

Over the nine-week trial, participants taking semaglutide started at a dose of 0.25 mg per week, which gradually increased to 1.0 mg in the final week -- a much lower dose than what’s typically ...

Semaglutide needle injection pen. New research suggests the drug can curb alcohol cravings (Alamy/PA) Weight-loss injections slash alcohol cravings and can curb heavy drinking, new research suggests.

A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

The blockbuster drug semaglutide ... people begin weekly injections of semaglutide for obesity or diabetes - and suddenly lose their desire for alcohol. This is the first randomized, placebo ...

Weight-loss injections could help users reduce their alcohol intake by curving cravings, new research suggests. In the first clinical trial of its kind, a weekly dose of semaglutide, also known as ...